Doctor profile · Federal record
Dr. NEELKANTHA AMATYA, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · LAKEWAY, TX
- NPI 1518190495
- Accepts Medicare
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
200 MEDICAL PKWY STE 110
LAKEWAY, TX 787381792
(512) 654-0150
fax (512) 654-0155 - Mailing address
-
PO BOX 844658
DALLAS, TX 752844658
Credentials & registration
- NPI registered
- August 2009 — 17 yrs on file
- Profile last updated
- September 4, 2020
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #R6515
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518190495. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,171
Distinct HCPCS
10
Medicare allowed
$257,296
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 6,000 | 62 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 531 | 341 | $128 | |
36415 |
Insertion of needle into vein for collection of blood sample | 170 | 114 | $8 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 121 | 93 | $178 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 117 | 59 | $34 | |
96372 |
Injection of drug or substance under skin or into muscle | 102 | 63 | $14 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 66 | 66 | $220 | |
10005 |
Fine needle aspiration biopsy using ultrasound guidance, first growth | 28 | 27 | $138 | |
10006 |
Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 18 | 14 | $60 | |
76536 |
Ultrasound scan of head and neck soft tissue | 18 | 18 | $116 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 406. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$1,944
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 24 | $424.87 | |
| Novo Nordisk Inc | 14 | $371.21 | |
| Dexcom, Inc. | 7 | $178.22 | |
| Abbott Laboratories | 10 | $139.62 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94.96 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $75.46 | |
| Insulet Corporation | 4 | $75.05 | |
| ABBVIE INC. | 3 | $73.88 | |
| Radius Health, Inc. | 4 | $73.04 | |
| Mannkind Corporation | 4 | $72.85 | |
| CeQur Corporation | 1 | $69.86 | |
| BETA BIONICS, INC. | 2 | $61.75 | |
| GENZYME CORPORATION | 2 | $56.95 | |
| Antares Pharma, Inc. | 3 | $55.14 | |
| Tandem Diabetes Care, Inc. | 2 | $40.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,873
Patients
903
Total drug cost
$1,619,884
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 611 | 184 | $13,303 |
| Ozempic (Semaglutide) | Brand | 357 | 82 | $511,980 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 263 | 71 | $343,104 |
| Atorvastatin Calcium | Generic | 249 | 91 | $3,654 |
| Metformin Hcl | Generic | 209 | 76 | $2,390 |
| Rosuvastatin Calcium | Generic | 176 | 65 | $4,095 |
| Mounjaro (Tirzepatide) | Brand | 154 | 42 | $289,116 |
| Lisinopril | Generic | 146 | 55 | $1,372 |
| Synthroid (Levothyroxine Sodium) | Brand | 126 | 41 | $13,612 |
| Trulicity (Dulaglutide) | Brand | 120 | 32 | $214,434 |